» Articles » PMID: 27795557

Re-emergence of Acute Myeloid Leukemia in Donor Cells Following Allogeneic Transplantation in a Family with a Germline DDX41 Mutation

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2016 Nov 1
PMID 27795557
Citations 47
Authors
Affiliations
Soon will be listed here.
Citing Articles

Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding.

Kida J, Chlon T Curr Opin Hematol. 2024; 32(2):67-76.

PMID: 39564659 PMC: 11781971. DOI: 10.1097/MOH.0000000000000854.


Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With a Germline Mutation.

Yoshida S, Semba Y, Takashima S, Kadowaki M, Takase K, Maeda T Case Rep Hematol. 2024; 2024:4611649.

PMID: 39526222 PMC: 11548944. DOI: 10.1155/2024/4611649.


Multifunctional role of DEAD-box helicase 41 in innate immunity, hematopoiesis and disease.

Ma J, Ross S Front Immunol. 2024; 15:1451705.

PMID: 39185415 PMC: 11341421. DOI: 10.3389/fimmu.2024.1451705.


The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies.

Kansal R Genes (Basel). 2024; 15(7).

PMID: 39062641 PMC: 11276294. DOI: 10.3390/genes15070863.


Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression.

Travaglini S, Marinoni M, Visconte V, Guarnera L Biomedicines. 2024; 12(5).

PMID: 38791019 PMC: 11118122. DOI: 10.3390/biomedicines12051054.


References
1.
Metzeler K, Herold T, Rothenberg-Thurley M, Amler S, Sauerland M, Gorlich D . Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood. 2016; 128(5):686-98. DOI: 10.1182/blood-2016-01-693879. View

2.
Langemeijer S, Kuiper R, Berends M, Knops R, Aslanyan M, Massop M . Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009; 41(7):838-42. DOI: 10.1038/ng.391. View

3.
Lewinsohn M, Brown A, Weinel L, Phung C, Rafidi G, Lee M . Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. Blood. 2015; 127(8):1017-23. PMC: 4968341. DOI: 10.1182/blood-2015-10-676098. View

4.
Churpek J, Pyrtel K, Kanchi K, Shao J, Koboldt D, Miller C . Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood. 2015; 126(22):2484-90. PMC: 4661171. DOI: 10.1182/blood-2015-04-641100. View

5.
Thol F, Friesen I, Damm F, Yun H, Weissinger E, Krauter J . Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol. 2011; 29(18):2499-506. DOI: 10.1200/JCO.2010.33.4938. View